Irritable bowel syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. According to the IBS diagnostic criteria of Western medicine, the patients with diarrhea as the main type and the patients with liver depression and spleen deficiency syndrome, spleen stomach weakness syndrome and liver depression and qi stagnation syndrome of traditional Chinese medicine. 2. Patients willing to sign informed consent. 3. Patients aged from 18 to 65 years.
Exclusion criteria
Exclusion criteria: 1. Pregnant or preparing for pregnancy, lactating women. 2. Patients with intestinal organic diseases, such as inflammatory bowel disease, intestinal tuberculosis and colonic polyps; 3. Patients with severe diseases of cardiovascular and cerebrovascular system, liver, kidney, hematopoietic system and tumors; 4. Patients with digestive tract operation records; 5. Patients with serious primary diseases and psychosis; 6. Patients with allergic history or drug and food allergy during the test period; 7. Patients who did not meet the inclusion criteria, did not use drugs according to the regulations, could not judge the efficacy or incomplete information, which affected the efficacy or safety judgment. 8. Patients considered unsuitable for this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM syndrome curative effect; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life Questionnaire (IBS-QOL);IBS symptom severity scale; | — |
Countries
China
Contacts
The First Affiliated Hospital of Guizhou University of traditional Chinese Medicine